MedPath

Effect of levamisole adjuvant plus hepatitis B vaccine in vaccine non-responders health care workers

Phase 2
Conditions
Hepatitis B vaccination.
Need for immunization against viral hepatitis
Registration Number
IRCT2014012110417N3
Lead Sponsor
Kermanshah University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

employees who have a history of hepatitis B vaccination and they aren’t immunized against this disease (HBsAb under 10); completing an informed consent form.
Exclusion criteria: employees with history or facing with positive HBsAg and HBcAb hepatitis

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Antibody titer to hepatitis B. Timepoint: One month after starting intervention - three months after the first intervention - one month after the last intervention. Method of measurement: Laboratory measurement of antibody titer.
Secondary Outcome Measures
NameTimeMethod
Side effects of medication or placebo. Timepoint: During the study period. Method of measurement: Interview.
© Copyright 2025. All Rights Reserved by MedPath